Intellectual property (IP) protection and traceability in biotechnology present ongoing challenges, particularly for genetically modified organisms (GMOs) and proprietary cell lines. Our latest white paper, developed in collaboration with Potter Clarkson, explores how barcoded version-controlled cells can provide a structured approach to addressing these challenges.
Our solutions—CellRepo® and GenoSignature™—offer a way to enhance provenance tracking, support verifiable ownership claims, and help minimise risks of unauthorised use. These tools contribute to a more transparent and effective framework for managing biological assets.
🔗 Read the full white paper here: Barcoded Version-Controlled Cells for Enhanced IP Protection and Traceability in Biotechnology
